Cargando…

Correction to “A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction”

Detalles Bibliográficos
Autores principales:	Roy, Saktimayee M., Minasov, George, Arancio, Ottavio, Chico, Laura W., Van Eldik, Linda J., Anderson, Wayne F., Pelletier, Jeffrey C., Watterson, D. Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154559/ https://www.ncbi.nlm.nih.gov/pubmed/32672466 http://dx.doi.org/10.1021/acs.jmedchem.0c01060

Ejemplares similares

A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction
por: Roy, Saktimayee M., et al.
Publicado: (2019)

Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models
por: Roy, Saktimayee M., et al.
Publicado: (2015)

Involvement of p38 MAPK in Synaptic Function and Dysfunction
por: Falcicchia, Chiara, et al.
Publicado: (2020)

A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model
por: Munoz, Lenka, et al.
Publicado: (2007)

Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology
por: Maphis, Nicole, et al.
Publicado: (2016)

Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic Dysfunction
por: Watterson, D. Martin, et al.
Publicado: (2013)

Target Engagement Analysis and Link to Pharmacodynamic Endpoint for a Novel Class of CNS-penetrant and Efficacious p38α MAPK Inhibitors
por: Bachstetter, Adam D., et al.
Publicado: (2014)

Sanguinarine Attenuates Neuropathic Pain by Inhibiting P38 MAPK Activated Neuroinflammation in Rat Model
por: Yu, Chao, et al.
Publicado: (2020)

Editorial: Role of Neuroinflammation in the Neuropsychiatric and Neurological Aspects of COVID-19
por: Tremblay, Marie-Eve, et al.
Publicado: (2022)

Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes
por: Zhou, Zhengqiu, et al.
Publicado: (2017)

First‐in‐Human Studies of MW01‐6‐189WH, a Brain‐Penetrant, Antineuroinflammatory Small‐Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers
por: Van Eldik, Linda J., et al.
Publicado: (2020)

Therapeutic treatment with the anti-inflammatory drug candidate MW151 may partially reduce memory impairment and normalizes hippocampal metabolic markers in a mouse model of comorbid amyloid and vascular pathology
por: Braun, David J., et al.
Publicado: (2022)

Modulating Neuroinflammation to Treat Neuropsychiatric Disorders
por: Radtke, Franziska A., et al.
Publicado: (2017)

Neuroinflammation: new vistas for neuropsychiatric research
por: Thibaut, Florence
Publicado: (2017)

Regulation of Microglia Activity by Glaucocalyxin-A: Attenuation of Lipopolysaccharide-Stimulated Neuroinflammation through NF-κB and p38 MAPK Signaling Pathways
por: Kim, Byung-Wook, et al.
Publicado: (2013)

Inhibition of HDAC6 alleviating lipopolysaccharide-induced p38MAPK phosphorylation and neuroinflammation in mice
por: Song, Yuanjian, et al.
Publicado: (2019)

Resveratrol attenuates neurological deficit and neuroinflammation following intracerebral hemorrhage
por: Cai, Jia-Chen, et al.
Publicado: (2018)

Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases
por: Lee, Moonhee, et al.
Publicado: (2016)

Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ)
por: Bachstetter, Adam D, et al.
Publicado: (2011)

CD38 in Neurodegeneration and Neuroinflammation
por: Guerreiro, Serge, et al.
Publicado: (2020)

Activation of melanocortin receptor 4 with RO27-3225 attenuates neuroinflammation through AMPK/JNK/p38 MAPK pathway after intracerebral hemorrhage in mice
por: Chen, Shengpan, et al.
Publicado: (2018)

Inhibition of Neuronal p38α, but not p38β MAPK, Provides Neuroprotection Against Three Different Neurotoxic Insults
por: Xing, Bin, et al.
Publicado: (2014)

Genetic knockout of myosin light chain kinase (MLCK210) prevents cerebral microhemorrhages and attenuates neuroinflammation in a mouse model of vascular cognitive impairment and dementia
por: Braun, David J., et al.
Publicado: (2019)

Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models
por: Hu, Cheng, et al.
Publicado: (2021)

Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin
por: Srodulski, Sarah, et al.
Publicado: (2014)

Neuropsychiatric changes following penetrating head injury in children
por: Badhiwala, Jetan H., et al.
Publicado: (2014)

PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease
por: Teich, Andrew F., et al.
Publicado: (2016)

TREM-2-p38 MAPK signaling regulates neuroinflammation during chronic cerebral hypoperfusion combined with diabetes mellitus
por: Zhang, Jiawei, et al.
Publicado: (2020)

Scopolamine promotes neuroinflammation and delirium-like neuropsychiatric disorder in mice
por: Cheon, So Yeong, et al.
Publicado: (2021)

Aprepitant Inhibits JNK and p38/MAPK to Attenuate Inflammation and Suppresses Inflammatory Pain
por: Yang, Yang, et al.
Publicado: (2022)

Inhibition of p38 MAPK decreases hyperglycemia-induced nephrin endocytosis and attenuates albuminuria
por: Woznowski, Magdalena Patrycja, et al.
Publicado: (2022)

p38 MAPK in MDS
por: Gañán‐Gómez, Irene, et al.
Publicado: (2015)

Deletion of p38α MAPK in microglia blunts trauma-induced inflammatory responses in mice
por: Morganti, Josh M., et al.
Publicado: (2019)

Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?
por: Chaves Filho, Adriano José Maia, et al.
Publicado: (2021)

Glibenclamide Attenuates Neuroinflammation and Promotes Neurological Recovery After Intracerebral Hemorrhage in Aged Rats
por: Jiang, Bing, et al.
Publicado: (2021)

Neuroinflammation and Neuromodulation in Neurological Diseases
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2019)

p38 MAPK Endogenous Inhibition Improves Neurological Deficits in Global Cerebral Ischemia/Reperfusion Mice
por: Hou, Kun, et al.
Publicado: (2022)

Editorial: Neurological Soft Signs in Neuropsychiatric Conditions
por: Toro, Pablo, et al.
Publicado: (2019)

Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders
por: Ratner, Marcia H., et al.
Publicado: (2019)

Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19
por: Pantelis, Christos, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i2pfr8809hrik9941o9op4q08s